242 related articles for article (PubMed ID: 16477657)
21. Update on cystic fibrosis-related bone disease: a special focus on children.
Sermet-Gaudelus I; Castanet M; Retsch-Bogart G; Aris RM
Paediatr Respir Rev; 2009 Sep; 10(3):134-42. PubMed ID: 19651384
[TBL] [Abstract][Full Text] [Related]
22. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
23. Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis.
Buntain HM; Schluter PJ; Bell SC; Greer RM; Wong JC; Batch J; Lewindon P; Wainwright CE
Thorax; 2006 Feb; 61(2):146-54. PubMed ID: 16384878
[TBL] [Abstract][Full Text] [Related]
24. Cystic fibrosis-associated liver disease: a population-based study.
Corbett K; Kelleher S; Rowland M; Daly L; Drumm B; Canny G; Greally P; Hayes R; Bourke B
J Pediatr; 2004 Sep; 145(3):327-32. PubMed ID: 15343185
[TBL] [Abstract][Full Text] [Related]
25. Adaptation of the Carter method to adjust lumbar spine bone mineral content for age and body size: application to children who were born preterm.
Smith CM; Coombs RC; Gibson AT; Eastell R
J Clin Densitom; 2006; 9(1):114-9. PubMed ID: 16731440
[TBL] [Abstract][Full Text] [Related]
26. Effect of diagnostic radioisotopes and radiographic contrast media on measurements of lumbar spine bone mineral density and body composition by dual-energy x-ray absorptiometry.
Sala A; Webber C; Halton J; Morrison J; Beaumont L; Zietak A; Barr R
J Clin Densitom; 2006; 9(1):91-6. PubMed ID: 16731437
[TBL] [Abstract][Full Text] [Related]
27. Relationships of acylated and des-acyl ghrelin levels to bone mineralization in obese children and adolescents.
Pacifico L; Anania C; Poggiogalle E; Osborn JF; Prossomariti G; Martino F; Chiesa C
Bone; 2009 Aug; 45(2):274-9. PubMed ID: 19393347
[TBL] [Abstract][Full Text] [Related]
28. Increased prevalence of risk factors for morbidity and mortality in the US Hispanic CF population.
Watts KD; Seshadri R; Sullivan C; McColley SA
Pediatr Pulmonol; 2009 Jun; 44(6):594-601. PubMed ID: 19437506
[TBL] [Abstract][Full Text] [Related]
29. Outcome in cystic fibrosis liver disease.
Rowland M; Gallagher CG; O'Laoide R; Canny G; Broderick A; Hayes R; Greally P; Slattery D; Daly L; Durie P; Bourke B
Am J Gastroenterol; 2011 Jan; 106(1):104-9. PubMed ID: 20736939
[TBL] [Abstract][Full Text] [Related]
30. Effect of ascites on bone density measurement in cirrhosis.
Labio ED; Del Rosario DB; Strasser SI; McCaughan GW; Crawford BA
J Clin Densitom; 2007; 10(4):391-4. PubMed ID: 17703977
[TBL] [Abstract][Full Text] [Related]
31. Liver disease in cystic fibrosis.
Rowland M; Bourke B
Curr Opin Pulm Med; 2011 Nov; 17(6):461-6. PubMed ID: 21881510
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of bone mineral density in thyrotoxicosis.
Udayakumar N; Chandrasekaran M; Rasheed MH; Suresh RV; Sivaprakash S
Singapore Med J; 2006 Nov; 47(11):947-50. PubMed ID: 17075661
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis.
Nash EF; Volling C; Gutierrez CA; Tullis E; Coonar A; McRae K; Keshavjee S; Singer LG; Durie PR; Chaparro C
Clin Transplant; 2012; 26(1):34-41. PubMed ID: 21272072
[TBL] [Abstract][Full Text] [Related]
34. Vitamin A levels in patients with CF are influenced by the inflammatory response.
Greer RM; Buntain HM; Lewindon PJ; Wainwright CE; Potter JM; Wong JC; Francis PW; Batch JA; Bell SC
J Cyst Fibros; 2004 Aug; 3(3):143-9. PubMed ID: 15463900
[TBL] [Abstract][Full Text] [Related]
35. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
Hitz MF; Jensen JE; Eskildsen PC
Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
[TBL] [Abstract][Full Text] [Related]
36. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
[TBL] [Abstract][Full Text] [Related]
37. Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis.
Buntain HM; Greer RM; Wong JC; Schluter PJ; Batch J; Lewindon P; Bell SC; Wainwright CE
J Paediatr Child Health; 2005 Jul; 41(7):317-22. PubMed ID: 16014134
[TBL] [Abstract][Full Text] [Related]
38. RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.
Rouster-Stevens KA; Langman CB; Price HE; Seshadri R; Shore RM; Abbott K; Pachman LM
Arthritis Rheum; 2007 Mar; 56(3):977-83. PubMed ID: 17328075
[TBL] [Abstract][Full Text] [Related]
39. Correlates of osteopenia in patients with cystic fibrosis.
Bhudhikanok GS; Lim J; Marcus R; Harkins A; Moss RB; Bachrach LK
Pediatrics; 1996 Jan; 97(1):103-11. PubMed ID: 8545201
[TBL] [Abstract][Full Text] [Related]
40. Use of body mass index percentile to identify fat-free mass depletion in children with cystic fibrosis.
Engelen MP; Schroder R; Van der Hoorn K; Deutz NE; Com G
Clin Nutr; 2012 Dec; 31(6):927-33. PubMed ID: 22607714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
